Registered Uganda · NDA

DOLUTEGRAVIR + LAMIVUDINE + TENOFOVIR

NDA/MAL/HDP/11569 ORAL SOLID ORDINARY FILM-COATED TABLETS 50 MG + 300 MG + 300 MG

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
NDA/MAL/HDP/11569
Registration date
25/09/2024
Expiry date
-
Status
Registered
Active ingredient
-
Strength
50 MG + 300 MG + 300 MG
Pack size
1.0X1.0X30.0 TABLET CONTAINER, 1.0X1.0X90.0 TABLET CONTAINER, 1.0X1.0X120.0 TABLET CONTAINER
Therapeutic class
-
Manufacturer / MAH
Cipla Limited
Applicant / LTR
CIPLA LTD.
Country of origin
INDIA
Manufacturer location
A-33 & 37/2/2, Rasayani, Taluka, Panvel, Navi Mumbai, Kaire, Maharashtra 410220, India

Source: National Drug Authority · fetched 2026-05-12 08:00:32 · updated 2026-09-12 04:00:20

Disclaimer: This information is sourced from National Drug Authority (Uganda). Always consult a qualified healthcare professional before using any medication.